Navigation Links
Mymetics Corporation Important Shareholders Information Conference Call
Date:8/25/2008

NYON, Switzerland, August 25 /PRNewswire-FirstCall/ -- Mymetics Corporation (OTC: MYMX), will be holding an important conference call on Wednesday August 27th 2008 at 1 PM New York Time to update all shareholders on the recent progress of the company, the June 30th 2008 Form 10-Q and to address recent press articles.

You may join the call Toll Free from the US at +1-866-591-4361 PIN 815 726 and from Europe at +41-800-329-326 PIN 815 726.

Corporate description:

Mymetics' primary objective is to develop vaccines and therapies to prevent and treat the effects of certain retroviruses and other infectious diseases, including the human immunodeficiency virus, or HIV, the virus that leads to acquired immunodeficiency syndrome, or AIDS. Mymetics has also recently acquired from a close scientific partner an advanced malaria vaccine project currently in phase Ib clinical trials. Additional applications of Mymetics's research include potential treatments and/or vaccines for human oncoviral leukemias, multiple sclerosis, and organ transplantation.

Contact:

Anthony Jessop

Senior Vice President Mymetics, Inc.

Phone North America: +1-303-800-6606

E-Mail: ajessop@mymetics.com


'/>"/>
SOURCE Mymetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
2. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
3. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
4. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
5. BioElectronics Corporation Announces Singapore and Malaysia Sales
6. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
7. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
8. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
9. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
10. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
11. Enova Medical Launches Exos Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Scientists at the Center for Learning and ... the California -based biopharmaceutical company Magceutics, ... for reversing memory decline in mice with Alzheimer,s Disease. ... improvement in advanced stage AD mice. The study is ... decline for advanced stage AD mice, and is also ...
(Date:5/16/2013)... Toronto, Canada (PRWEB) May 16, 2013 ... years and costs over one billion dollars. Despite this ... market. With stakes this high, is your clinical trial ... and deliver the best outcomes? , Dr. Frederic Sax, ... Quintiles, will discuss the use of data, information and ...
(Date:5/16/2013)... 16, 2013 Reportlinker.com announces ... is available in its catalogue: ... for Acute Coronary Syndromes - APAC ... http://www.reportlinker.com/p01182969/MediPoint-Diagnostic-Cardiac-Biomarkers-for-Acute-Coronary-Syndromes---APAC-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic MediPoint: ... Syndromes - APAC Analysis and Market ...
(Date:5/16/2013)... DNA Genotek, a leading provider of products for ... program in conjunction with the African Society of Human Genetics ... reduce the cost of DNA collection for locally ... and Health in Africa (H3 Africa) Initiative and to facilitate ... the AfSHG is to build the capacity of ...
Breaking Biology Technology:Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3
... Selexis SA, a Swiss-based biotechnology company with technologies ... yield and stable mammalian cell lines for therapeutic ... from the Company will be participating in the ... held Jun 27-30 in Washington, D.C. at the ...
... of a new quasiparticle called the "hybrid plasmon ... photonic circuits and optical computing for the 21st ... (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab) have ... generation on-chip optical communication systems. "We ...
... Inc. (Nasdaq: AMLN ) will be presenting at the ... 2011, at 12:20 p.m. ET / 9:20 a.m. PT ... Life Sciences Conference on Wednesday, June 8, 2011, at 10:00 a.m. ... New York.  Daniel M. Bradbury, president and chief executive officer ...
Cached Biology Technology:Selexis SA to Partner and Exhibit at BIO 2011 in Washington DC 2Nanoscale waveguide for future photonics 2Nanoscale waveguide for future photonics 3Nanoscale waveguide for future photonics 4
(Date:5/18/2013)... Research presented at Digestive Disease Week (DDW) ... diet and lifestyle. , Individuals suffering from ... strength, fatigue and poor quality of life. These ... remission. A randomized, double blind, placebo-controlled study found ... corresponded to significant relief of these symptoms. ...
(Date:5/17/2013)... MD (May 18, 2013) The AGA Research Foundation ... into the relationship between the gut microbiota, one of ... and disease. , The AGA Research Awards Panel ... from Massachusetts General Hospital and Harvard Medical School, Boston, ... recipient. Dr. Chan will receive $25,000 of funding, commencing ...
(Date:5/17/2013)... State University of New Jersey, and City University of ... Visikol TM that effectively clears organisms to be ... of chloral hydrate, which is one of the few ... regulated by the Drug Enforcement Administration (DEA) due to ... clearing agents, are vital for viewing organisms under a ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3New gut microbiome research to explore red meat -- colorectal cancer pathway 2New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3
... 4, 2011 Venture capital (VC) funding in the ... and Medical Device industries, recovered in terms of dollar ... a new PwC US report, "A Case for Cautious ... PricewaterhouseCoopers LLP/National Venture Capital Association MoneyTree™ Report, based on ...
... ecology, the removal or addition of a predator to an ... species. For the first time, scientists have observed the same ... that decimated ocean life 360 million years ago. What ... according to a paper published today in Proceedings of ...
... Durham, NC Most of us wouldn,t consider slow-moving snails ... distant past, snail metabolism sped up, says a new study ... "Many of the marine snails we recognize today such ... twice as much energy to survive as their ancestors did," ...
Cached Biology News:Life Sciences Venture Capital Investment Level Rebounds in Q1 2011 but Deal Volume Declines, According to the MoneyTree Report 2Life Sciences Venture Capital Investment Level Rebounds in Q1 2011 but Deal Volume Declines, According to the MoneyTree Report 3Life Sciences Venture Capital Investment Level Rebounds in Q1 2011 but Deal Volume Declines, According to the MoneyTree Report 4The winners of mass extinction: With predators gone, prey thrives 2The winners of mass extinction: With predators gone, prey thrives 3Marine snails get a metabolism boost 2
Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera)...
Recombinant Human Erythropoietin (Tissue Culture Grade)...
Acrylamide PAGE 40% Solution, 1 l. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Gel Casting Chemicals....
Recombinant Mouse IL-23, CF...
Biology Products: